Global Chorea Treatment Market Growth (Status and Outlook) 2025-2031

According to this study, the global Chorea Treatment market size will reach US$ million by 2031.

Chorea is an abnormal involuntary movement characterized by brief, abrupt, unpredictable, irregular, non-stereotyped movements. Chorea may worsen with anxiety and voluntary movements, and subsides during sleep The major causes of chorea include use of oral contraceptives, pregnancy, autoimmune disorders, paraneoplastic syndromes, hyperthyroidism, hypoparathyroidism, and hyperglycemia.

United States market for Chorea Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Chorea Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Chorea Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Chorea Treatment players cover Medtronic, Boston Scientific, Aleva Neurotherapeutics, Teva Pharmaceutical, Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Chorea Treatment Industry Forecast” looks at past sales and reviews total world Chorea Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Chorea Treatment sales for 2025 through 2031. With Chorea Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chorea Treatment industry.

This Insight Report provides a comprehensive analysis of the global Chorea Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Chorea Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chorea Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chorea Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chorea Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Chorea Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:
Medication
Surgery Therapy

Segmentation by Application:
Hospitals
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Boston Scientific
Aleva Neurotherapeutics
Teva Pharmaceutical
Pfizer
GlaxoSmithKline
Bausch Health Companies
LivaNova
Lundbeck
Ipsen
Alnylam Pharmaceuticals
Prana Biotechnology
RespireRx Pharmaceuticals
Vertex Pharmaceuticals
SOM Biotech

Please note: The report will take approximately 2 business days to prepare and deliver. Show more